Development of anti-HER2 monoclonal antibodies for gastric cancer

被引：0
|
作者：
Nanamiya, Ren [1 ]
Suzuki, Hiroyuki [2 ]
Kato, Yukinari [1 ,2 ]
机构：
[1] Tohoku Univ, Dept Antibody Drug Dev, Grad Sch Med, Sendai, Miyagi, Japan
[2] Tohoku Univ, Dept Mol Pharmacol, Grad Sch Med, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1164
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [31] Margetuximab Anti-HER2 monoclonal antibody Treatment of metastatic HER2-positive breast cancer Treatment of HER2-positive gastric or gastroeso-phageal junction cancer
    Hanna, K. S.
    DRUGS OF THE FUTURE, 2021, 46 (03) : 191 - 195
  • [32] Cross Reactivity of Clinically Validated Anti-HER2 Antibodies
    Schrohl, A-S
    Jensen, S. S.
    Pedersen, H. C.
    Nielsen, S. L.
    Brunner, N.
    CANCER RESEARCH, 2010, 70
  • [33] Pertummab - Humanized anti-HER2 monoclonal antibody HER dimerization inhibitor oncolytic
    Langdon, S. P.
    Mullen, P.
    Faratian, D.
    Harrison, D. J.
    Cameron, D. A.
    Hasmann, M.
    DRUGS OF THE FUTURE, 2008, 33 (02) : 123 - 130
  • [34] Novel murine anti-HER2 monoclonal antibodies to induce apoptosis and regulate miR-21 in breast cancer cell.
    Kim, Alice Y.
    Zer, Cindy
    Williams, John C.
    Press, Michael F.
    Park, Jinha Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines
    Mandler, R
    Wu, CC
    Sausville, EA
    Roettinger, AJ
    Newman, DJ
    Ho, DK
    King, CR
    Yang, DJ
    Lippman, ME
    Landolfi, NF
    Dadachova, E
    Brechbiel, MW
    Waldmann, TA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (19) : 1573 - 1581
  • [36] Characterization of glycoengineered anti-HER2 monoclonal antibodies produced by using a silkworm-baculovirus expression system
    Egashira, Yuriko
    Nagatoishi, Satoru
    Kiyoshi, Masato
    Ishii-Watabe, Akiko
    Tsumoto, Kouhei
    JOURNAL OF BIOCHEMISTRY, 2018, 163 (06): : 481 - 488
  • [37] Evolution of anti-HER2 therapies for cancer treatment
    Parakh, Sagun
    Gan, Hui K.
    Parslow, Adam C.
    Burvenich, Ingrid J. G.
    Burgess, Antony W.
    Scott, Andrew M.
    CANCER TREATMENT REVIEWS, 2017, 59 : 1 - 21
  • [38] Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles
    Li, Wei
    Zhao, He
    Qian, Weizhu
    Li, Huafei
    Zhang, Li
    Ye, Zengwei
    Zhang, Ge
    Xia, Mao
    Li, Jinfeng
    Gao, Jie
    Li, Bohua
    Kou, Geng
    Dai, Jianxin
    Wang, Hao
    Guo, Yajun
    BIOMATERIALS, 2012, 33 (21) : 5349 - 5362
  • [39] Annular atrophic lichen planus induced by anti-HER2 antibodies
    Chawla, Sumir
    Turner, Nicholas
    Terlizzo, Monica
    Heelan, Kara
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (02) : 210 - 212
  • [40] Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model
    Matsui, Y
    Inomata, M
    Tojigamori, M
    Sonoda, K
    Shiraishi, N
    Kitano, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 681 - 685
12345